---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-026669"
form_type: "8-K"
ticker: "BDSX"
cik: "0001439725"
company_name: "BIODESIX INC"
filed_at: "2022-12-16T23:59:59+00:00"
generated_at: "2026-06-21T03:15:45.622134+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Biodesix appoints Lawrence T. Kennedy to Board of Directors, effective Jan 3, 2023

## Summary
- Kennedy appointed to Board and Audit Committee, effective Jan 3, 2023.
- He brings 20+ years healthcare operating, finance, and investment experience; managing partner/CEO of Westwood Management.
- Initial equity grant of $375K (50% NQSOs, 50% RSUs) plus prorated annual grant of $46,411 in RSUs.
- Senior Mgmt Bonus to Equity Plan amended: Multiplier reduced from 4 to 3, and Company may limit election by percentage.

## SEC filing metadata
- accession: 0000950170-22-026669
- form_type: 8-K
- ticker: BDSX
- cik: 0001439725
- company_name: BIODESIX INC
- filed_at: 2022-12-16T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1439725/000095017022026669/0000950170-22-026669-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1439725/000095017022026669/bdsx-20221214.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-026669
- JSON: https://secwatch.observer/filing/0000950170-22-026669.json
- Plain text: https://secwatch.observer/filing/0000950170-22-026669.txt

## Key facts
- Executive change
  Lawrence (Lair) T. Kennedy was appointed as Director at BIODESIX INC.
  - Action: appointed
  - Role: Director
  source text: On December 15, 2022, Lawrence (Lair) T. Kennedy was elected and appointed to the Board of Directors of Biodesix, Inc. (the “Company”), with such appointment to be effective and service to commence on January 3, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1439725/000095017022026669/0000950170-22-026669-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.